Organization Profile

You just read:

Sanofi's Lyxumia® (lixisenatide) Showed More Pronounced After-Test-Meal Blood Sugar Lowering Than Liraglutide When Both Were Added to Insulin Glargine

News provided by

Sanofi Diabetes

Jun 14, 2014, 13:52 ET